DOPAMINE ACTIVATION OF THE ARACHIDONIC-ACID CASCADE AS A BASIS FOR D1/D2 RECEPTOR SYNERGISM

被引:257
作者
PIOMELLI, D
PILON, C
GIROS, B
SOKOLOFF, P
MARTRES, MP
SCHWARTZ, JC
机构
[1] Unité de Neurobiologie et Pharmacologie (U. 109) de l'INSERM, Centre Paul Broca, 75014 Paris
关键词
D O I
10.1038/353164a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
UNDERSTANDING the actions of the neurotransmitter dopamine in the brain is important in view of its roles in neuropsychiatric illnesses 1. Dopamine D1 receptors, which stimulate both adenylyl cyclase 2 and phospholipase C3, and D2 receptors, which inhibit them 4,5, can nevertheless act synergistically to produce many electrophysiological and behavioural responses 6. Because this functional synergism can occur at the level of single neurons, another, as yet unidentified, signalling pathway activated by dopamine has been hypothesized 7. We report here that in Chinese hamster ovary (CHO) cells transfected with the D2 receptor complementary DNA, D2 agonists potently enhance arachidonic acid release, provided that such release has been initiated by stimulating constitutive purinergic receptors or by increasing intracellular Ca2+. In CHO cells expressing D1 receptors, D1 agonists exert no such effect. When D1 and D2 receptors are coexpressed, however, activation of both subtypes results in a marked synergistic potentiation of arachidonic acid release. The numerous actions of arachidonic acid and its metabolites in neuronal signal transduction 8 suggest that facilitation of its release may be implicated in dopaminergic responses, such as feedback inhibition mediated by D2 autoreceptors, and may constitute a molecular basis for D1/D2 receptor synergism.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 28 条
  • [1] INOSITOL PHOSPHATES AND CELL SIGNALING
    BERRIDGE, MJ
    IRVINE, RF
    [J]. NATURE, 1989, 341 (6239) : 197 - 205
  • [2] INHIBITION BY DOPAMINE OF (NA++K+)ATPASE ACTIVITY IN NEOSTRIATAL NEURONS THROUGH D1 AND D2 DOPAMINE RECEPTOR SYNERGISM
    BERTORELLO, AM
    HOPFIELD, JF
    APERIA, A
    GREENGARD, P
    [J]. NATURE, 1990, 347 (6291) : 386 - 388
  • [3] BLEY KR, 1990, NEURON, V2, P379
  • [4] BURCH RM, 1989, MOL NEUROBIOL, V3, P156
  • [5] THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA
    CARLSSON, A
    [J]. NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) : 179 - 186
  • [6] REVIEW - D1 DOPAMINE RECEPTOR - THE SEARCH FOR A FUNCTION - A CRITICAL-EVALUATION OF THE D1/D2 DOPAMINE RECEPTOR CLASSIFICATION AND ITS FUNCTIONAL IMPLICATIONS
    CLARK, D
    WHITE, FJ
    [J]. SYNAPSE, 1987, 1 (04) : 347 - 388
  • [7] THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING
    DALTOSO, R
    SOMMER, B
    EWERT, M
    HERB, A
    PRITCHETT, DB
    BACH, A
    SHIVERS, BD
    SEEBURG, PH
    [J]. EMBO JOURNAL, 1989, 8 (13) : 4025 - 4034
  • [8] DOPAMINE INHIBITS ADENYLATE-CYCLASE IN HUMAN PROLACTIN-SECRETING PITUITARY ADENOMAS
    DECAMILLI, P
    MACCONI, D
    SPADA, A
    [J]. NATURE, 1979, 278 (5701) : 252 - 254
  • [9] NMDA RECEPTORS ACTIVATE THE ARACHIDONIC-ACID CASCADE SYSTEM IN STRIATAL NEURONS
    DUMUIS, A
    SEBBEN, M
    HAYNES, L
    PIN, JP
    BOCKAERT, J
    [J]. NATURE, 1988, 336 (6194) : 68 - 70
  • [10] EXTON JH, 1990, J BIOL CHEM, V265, P1